14 recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Recruiting 14 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Timolol Maleate 0.25% Ophthalmic Solution - Open Angle Glaucoma (OAG), Glaucoma | Phase 4 | Recruiting | Brett King | 13 | 2026-10-01 | 2026-10-28 |
| Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension Netarsudil Ophthalmic Solution (Rhopressa), Artificial Tears (AT) - Glaucoma, Ocular Hypertension | Phase 4 | Recruiting | Indiana University | 50 | 2026-06-05 | 2026-06-11 |
| Rocklatan vs Latanoprost Post-DSLT Rocklatan 0.02%-0.005% Ophthalmic Solution, Latanoprost 0.005% Ophthalmic Solution - Glaucoma | Phase 4 | Recruiting | Eye Centers of Southeast Texas | 36 | 2026-05-14 | 2026-05-22 |
| Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use Durysta, Bimatoprost Intracameral Implant 10 µg - Glaucoma, Open-Angle Glaucoma | Phase 4 | Recruiting | University of Miami | 20 | 2026-02-09 | 2026-03-05 |
| Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma iStent infinite trabecular micro-bypass system model iS3, iDose TR (Travoprost intracameral Implant) 75mcg - Open Angle Glaucoma, Pigmentary Glaucoma | Phase 4 | Recruiting | Jonathon Myers | 20 | 2026-01-05 | 2025-11-14 |
| 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution, Latanoprost 0.005% Ophthalmic Solution - Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Recruiting | Mayo Clinic | 30 | 2025-11-21 | 2026-05-01 |
| Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma Brimonidine Tartrate Ophthalmic 0.025% - Glaucoma | Phase 4 | Recruiting | Insight Eyecare Specialties, Inc. dba Vision Source Eyecare, | 35 | 2025-11-01 | 2025-11-18 |
| Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost Simbrinza 0.2%-1% Ophthalmic Suspension, Rocklatan 0.02%-0.005% Ophthalmic Solution, Cosopt PF 2%-0.5% Ophthalmic Solution - Open Angle Glaucoma | Phase 4 | Recruiting | Prairie Eye Center | 70 | 2025-05-14 | 2025-05-15 |
| Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery, Sham procedure in conjunction with cataract surgery - Glaucoma, Open-angle, Ocular Hypertension (OHT) | Phase 4 | Recruiting | Glaukos Corporation | 132 | 2025-01-13 | 2026-01-21 |
| A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma Oral semaglutide, Placebo - Primary Open Angle Glaucoma (POAG), Open-Angle Glaucoma | Phase 4 | Recruiting | Glostrup University Hospital, Copenhagen | 126 | 2025-01-01 | 2025-01-24 |
| Travoprost Intraocular Implant + iStent Infinite Travoprost Intraocular Implant, iStent infinite, Sham procedure - Glaucoma, Open-Angle | Phase 4 | Recruiting | Glaukos Corporation | 150 | 2023-09-14 | 2026-06-02 |
| Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors Insulin, Artificial tear - Dry Eye, Glaucoma | Phase 4 | Recruiting | Barbara Burgos Blasco | 100 | 2023-02-08 | 2024-10-22 |
| Retinal Blood Flow and Autoregulation Indocyanine Green Angiography, Isocapnic Oxygen, Ocular Imaging with Optical Coherence Tomography (OCT) and Adaptive Optics (AO) - Glaucoma | Phase 4 | Recruiting | University of Maryland, Baltimore | 90 | 2022-05-23 | 2025-12-02 |
| Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells Xalatan, Monoprost - Glaucoma, Ocular Hypertension | Phase 4 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 28 | 2021-09-01 | 2023-11-18 |
Glaucoma, Open-Angle (8) · Ocular Hypertension (5) · Dry Eye Syndromes (1) · Exfoliation Syndrome (1) · Hyperemia (1)
Eye Diseases (14) · Ocular Hypertension (9) · Cardiovascular Diseases (1) · Iris Diseases (1) · Lacrimal Apparatus Diseases (1) · Uveal Diseases (1) · Vascular Diseases (1)
Latanoprost (4) · Ophthalmic Solutions (4) · Lubricant Eye Drops (2) · netarsudil (2) · Cataract Extraction (1) · Insulin (1) · Timolol (1) · Tomography, Optical Coherence (1) · dorzolamide-timolol combination (1) · semaglutide (1)
Glaukos Corporation (2) · Barbara Burgos Blasco (1) · Brett King (1) · Copenhagen University Hospital, Rigshospitalet (1) · Eye Centers of Southeast Texas (1) · Glostrup University Hospital, Copenhagen (1) · Indiana University (1) · Insight Eyecare Specialties, Inc. dba Vision Source Eyecare, (1) · Jonathon Myers (1) · Mayo Clinic (1) · Prairie Eye Center (1) · University of Maryland, Baltimore (1) · University of Miami (1)
United States (11) · Denmark (2) · Spain (1)
Arthur J Sit, MD, MS (1) · Barbara Burgos Blasco, MD, PhD (1) · Dilru Amarasekera, MD (1) · Kevin Talbot, MD (1) · Miriam Kolko, MD, PhD (1) · Sandra Yeh, MD (1) · Swarup S Swaminathan, MD (1)
2019 (1)